Eli Lilly and Company (LLY.DE)

EUR 740.8

(-1.23%)

Revenue Summary of Eli Lilly and Company

  • Eli Lilly and Company's latest annual revenue in 2023 was 34.12 Billion USD , up 19.56% from previous year.
  • Eli Lilly and Company's latest quarterly revenue in 2024 Q2 was 11.3 Billion USD , up 28.91% from previous quarter.
  • Eli Lilly and Company reported a annual revenue of 28.54 Billion USD in annual revenue 2022, up 0.79% from previous year.
  • Eli Lilly and Company reported a annual revenue of 28.31 Billion USD in annual revenue 2021, up 15.4% from previous year.
  • Eli Lilly and Company reported a quarterly revenue of 11.43 Billion USD for 2024 Q3, up 1.21% from previous quarter.
  • Eli Lilly and Company reported a quarterly revenue of 8.76 Billion USD for 2024 Q1, down -6.26% from previous quarter.

Annual Revenue Chart of Eli Lilly and Company (2023 - 1989)

Historical Annual Revenue of Eli Lilly and Company (2023 - 1989)

Year Revenue Revenue Growth
2023 34.12 Billion USD 19.56%
2022 28.54 Billion USD 0.79%
2021 28.31 Billion USD 15.4%
2020 24.53 Billion USD 9.95%
2019 22.31 Billion USD 3.84%
2018 21.49 Billion USD -6.03%
2017 22.87 Billion USD 7.77%
2016 21.22 Billion USD 6.33%
2015 19.95 Billion USD 1.75%
2014 19.61 Billion USD -15.13%
2013 23.11 Billion USD 2.25%
2012 22.6 Billion USD -6.93%
2011 24.28 Billion USD 5.25%
2010 23.07 Billion USD 5.68%
2009 21.83 Billion USD 7.15%
2008 20.37 Billion USD 9.36%
2007 18.63 Billion USD 18.75%
2006 15.69 Billion USD 7.14%
2005 14.64 Billion USD 5.68%
2004 13.85 Billion USD 10.14%
2003 12.58 Billion USD 13.59%
2002 11.07 Billion USD -4.03%
2001 11.54 Billion USD 6.26%
2000 10.86 Billion USD 8.59%
1999 10 Billion USD 8.29%
1998 9.23 Billion USD 8.44%
1997 8.51 Billion USD 15.94%
1996 7.34 Billion USD 8.62%
1995 6.76 Billion USD 18.42%
1994 5.71 Billion USD -11.48%
1993 6.45 Billion USD 4.62%
1992 6.16 Billion USD 7.71%
1991 5.72 Billion USD 10.29%
1990 5.19 Billion USD 24.33%
1989 4.17 Billion USD 2.6%

Peer Revenue Comparison of Eli Lilly and Company

Name Revenue Revenue Difference
Bayer Aktiengesellschaft 47.63 Billion EUR 28.366%
Sanofi 46.03 Billion EUR 25.87%